CytoVas, LLC

CytoVas is a diagnostic company focused on discovering novel markers for vascular disease. Using computational bioinformatics and high dimensional small particle detection through flow cytometry and eliminating subjectivity using proprietary computational approaches, the vascular health profile assay correlates novel markers to outcomes in diseases like cardiovascular disease (CVD), chronic kidney disease (CKD), peripheral artery disease (PAD), pulmonary arterial hypertension (PAH) and type 2 diabetes mellitus (T2D).

CytoVas is focused on discovering novel markers for vascular disease
Share